IXICO plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Mark Warne, was filed 15 Jul 2026.
IXICO plc: what insiders have been doing
This page follows insider dealings at IXICO plc as filed with RNS (LSE), a company from the Health Care sector. Between 4 November 2025 and 4 November 2026, 1 insider published 1 filing.
The flow runs one way only: 1 insider bought (1 purchase totalling €4,673) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 board member among the declarants. Biggest ticket of the year: €4,673, bought by Mark Warne and made public on 15 July 2026 (0.024% of market cap).
For context, the typical company on the same exchange (median of 832 companies) published 6 filings over the same period, against 1 filing here. The full history, which starts in 2013, counts 13 purchases against no sales.
The last purchase on record was published on 15 July 2026, which is 116 days ago.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate IXICO plc Strong Buy (bullish), based on 1 analysts. Average price target: £0.26.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended September 2025 · cache
- 50,006 shares@ £0.07980.024% mcap100.0% of flowLondonRNS:c11e0f11-e76c-4b6a-b393-b5eda8bfa32dCanonical exit: 13 Oct 2026 (T+90)
- 526,315 shares@ £0.095100.0% of flowOff Market TransactionRNS:5406287-0
- 105,263 shares@ £0.095100.0% of flowOff Market TransactionRNS:5406287-1
- 105,263 shares@ £0.095100.0% of flowOff Market TransactionRNS:5406287-2
- 52,631 shares@ £0.095100.0% of flowOff Market TransactionRNS:5406287-3
- 44,000 shares@ £0.1203100.0% of flowFrankfurt (Germany)RNS:5390671Canonical exit: 13 Jan 2025 (T+90)
- 70,175 shares@ £0.285100.0% of flowLondon Stock Exchange, AIM Market (IXI)ISIN GB00BFXR4C20FCA-NSM:LSE20190318122431_14006003_20200326185133776_13171Canonical exit: 16 Jun 2019 (T+90)
- 53,300 shares@ £0.28100.0% of flowLondon Stock Exchange, AIM Market (IXI)ISIN GB00BFXR4C20FCA-NSM:LSE20190313070006_13999839_20200326185134052_18686Canonical exit: 10 Jun 2019 (T+90)
- 60,606 shares@ £0.33100.0% of flowLondon Stock Exchange, AIM Market (IXI)ISIN GB00BCLY7L40FCA-NSM:LSE20180523152945_13652782_20200330111431421_6422Canonical exit: 21 Aug 2018 (T+90)
- 30,537 shares@ £0.2425100.0% of flowLondon Stock Exchange, AIM Market (IXI)ISIN GB00BCLY7L40FCA-NSM:LSE20170329153002_13176087_20200330131526771_23833
- 25,309 shares@ £0.2425100.0% of flowLondon Stock Exchange, AIM Market (IXI)ISIN GB00BCLY7L40FCA-NSM:LSE20170329153002_13176085_20200330131526771_23834
- 29,773 shares@ £0.01100.0% of flowLondon Stock Exchange, AIM Market (XLON)FCA-NSM:LSE20160926171453_012979244_20200330143620027_19480
- 28,366 shares@ £0.3525100.0% of flowFCA-NSM:LSE20160301103536_012718537_20200330143605784_775Canonical exit: 30 May 2016 (T+90)
- 10,000 shares@ £0.3368100.0% of flowFCA-NSM:LSE20160205070006_012687714_20200330143552266_4469Canonical exit: 4 May 2016 (T+90)
- 45,899 shares@ £0.3268100.0% of flowFCA-NSM:LSE20160204070008_012685979_20200330143552219_3429Canonical exit: 3 May 2016 (T+90)
- 19,267 shares@ £0.519FCA-NSM:LSE20140721163340_012024488_20200330172020763_12061Canonical exit: 19 Oct 2014 (T+90)
- 35,517 shares@ £0.56FCA-NSM:LSE20131118180003_011778090_20200330164714570Canonical exit: 16 Feb 2014 (T+90)
- 9,729 shares@ £0.5139FCA-NSM:LSE20131101160129_011761818_20200330164713935Canonical exit: 30 Jan 2014 (T+90)
- 4,000 shares@ £0.515FCA-NSM:LSE20131031112606_011759561_20200330164716879Canonical exit: 29 Jan 2014 (T+90)
- 16,500 shares@ £0.59FCA-NSM:LSE20131021132244_011748122_20200330164716633Canonical exit: 19 Jan 2014 (T+90)
20 of 20 declarations
About IXICO plc
IXICO plc is a company specializing in data analytics for the healthcare sector, particularly in clinical trials. It provides solutions to enhance decision-making in drug development.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
